News and views
Brentuximab vedotin (Adcetris®) has been officially accepted as a treatment for some people with Hodgkin lymphoma in Scotland.
The Scottish Medicines Consortium (SMC) today (13/10/2014) announced that it has accepted the drug for restricted use by NHS Scotland.
Two of our patient information booklets have just received awards from the British Medical Association - the professional body for UK doctors.
‘When I was diagnosed with lymphoma I was in my early thirties and felt my world had come crashing down around me. The Lymphoma Association gave me the strength and positivity I so desperately needed.’
Patients in the UK with relapsed or refractory mantle cell lymphoma have access to the drug ibrutinib through the MED (Medicines Evaluation Board) compassionate use programme.
We’ve now released videos of our 2014 patient and carer conference which you can watch online or on DVD.